BioVentures will increase diversity in the health technology sector by introducing the ACTIVE program

Little Rock, Arkansas – Launching their new ACTIVE program in collaboration with The Venture Center, BioVentures hopes to provide socially and economically disadvantaged innovators (SEDI) with an advantage.

By supporting early-stage healthcare and health tech startups, ACTIVE is especially focused in addressing underrepresentation within the health tech industry.

“This initiative represents a significant step towards equality and inclusion,” said Kevin Sexton, MD, principal investigator. “This isn’t merely a financial boost; it’s a clarion call for innovation and inclusivity in Arkansas’ health tech domain. With the Capital Readiness Program’s trust, BioVentures and ACTIVE are embarking on an adventure where the talents of our socially and economically disadvantaged entrepreneurs will be the cornerstone of the next generation of health care solutions in the state.”

Officials have stated in a news release that 25 applicants will be accepted for the one-year ACTIVE program. Access to the following services will be available to participants:

• Entrepreneurship bootcamps for essential business skills.
• Assistance in business setup for a strong foundation.
• Guidance on funding options, including loans and grants.
• Networking opportunities with venture capitalists.
• Personalized mentorship for tailored advice.
• Legal support in healthcare compliance and intellectual property.

“The Venture Center is excited to offer a skill training bootcamp for this initiative,” said Daniel Schutte, VP of Strategic Partnerships at The Venture Center. “Our goal is to equip promising healthcare innovators with the tools and knowledge they need to scale their businesses and make a lasting impact in the industry.”

The University of Arkansas at Pine Bluff and Philander Smith College are partners in the program, which is financed by the Minority Business Development Agency’s Capital Readiness Program.

Candidates must fill out an online form explaining their background and business idea.

April 15 is the deadline for entries. The selection of applicants shall be predicated by the distinctiveness of their medical remedy and its capacity to influence society.